Department of Thoracic Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan Province, China.
World J Surg Oncol. 2023 Feb 10;21(1):41. doi: 10.1186/s12957-023-02930-0.
As the preoperative examination of esophageal cancer has improved, the likelihood of finding diseases in other organs that require surgical treatment has also increased. The purpose of this study was to explore the feasibility of combined surgery for esophageal cancer by analyzing the occurrence of postoperative complications in patients with esophageal cancer.
The clinical characteristics of 1566 patients with esophageal cancer who underwent thoracic surgery in our hospital between January 2017 and September 2022 were analyzed retrospectively. The feasibility of combined surgery for esophageal cancer was analyzed by comparing postoperative complications in patients who underwent simple esophageal cancer surgery (SEC) with those in patients who underwent combined surgery for esophageal cancer (COEC). The tendency scores of patients in the COEC and SEC groups (1:2) were matched to balance the confounding clinical factors, and the difference in postoperative complications was further analyzed. Moreover, we performed a subgroup analysis of esophagectomy combined with lung resection (ECL). In addition, the independent risk factors for postoperative Clavien-Dindo ≥ grade III complications of esophageal cancer were analyzed by multivariate logistic regression.
A total of 1566 patients (1147 (73.2%) males and 419 (26.8%) females), with an average age of 64.2 years, were analyzed. There was no significant difference in postoperative complications between the SEC and COEC groups according to the Clavien-Dindo classification (P=0.713). An analysis of the complications revealed that those in the COEC group had a higher incidence of lung consolidation than those in the SEC group (P=0.007). However, when we performed propensity score matching (PSM) on the SEC and COEC groups, there was still no significant difference in complications according to the Clavien-Dindo classification (P=0.346); furthermore, when a detailed analysis of complications was performed, there was no significant difference between the two. In subgroup analysis, after we performed PSM in ECL patients and SEC patients, we also found no significant difference in postoperative complications between patients with ECL and patients with SEC. In addition, we found that a history of diabetes (OR=1.604, P=0.029, 95% CI=1.049-2.454), a history of coronary heart disease (OR=1.592, P=0.046, 95% CI=1.008-2.515), diffusing capacity of the lungs for carbon monoxide (DLCO) (OR=0.916, P=0.024, 95% CI=0.849-0.988), and ALB level (OR=0.955, P=0.007, 95% CI=0.924-0.987) were independent factors that influenced postoperative complications in esophageal cancer patients with grade III or higher complications.
Combined surgery for esophageal cancer does not increase the incidence of postoperative complications. In addition, a history of diabetes mellitus or coronary heart disease, carbon monoxide dispersion, and preoperative ALB level are independent risk factors for grade III or higher postoperative complications of esophageal cancer.
随着食管癌术前检查的提高,发现需要手术治疗的其他器官疾病的可能性也增加了。本研究旨在通过分析食管癌患者术后并发症的发生情况,探讨食管癌联合手术的可行性。
回顾性分析我院 2017 年 1 月至 2022 年 9 月期间 1566 例接受胸外科手术的食管癌患者的临床特征。通过比较单纯食管癌手术(SEC)和食管癌联合手术(COEC)患者术后并发症,分析食管癌联合手术的可行性。COEC 组和 SEC 组(1:2)的倾向评分匹配以平衡混杂的临床因素,进一步分析术后并发症的差异。此外,我们对食管切除术联合肺切除术(ECL)进行了亚组分析。另外,通过多变量逻辑回归分析食管癌术后 Clavien-Dindo 分级≥III 级并发症的独立危险因素。
共分析了 1566 例患者(男性 1147 例,占 73.2%,女性 419 例,占 26.8%,平均年龄 64.2 岁)。SEC 组和 COEC 组的术后并发症根据 Clavien-Dindo 分级无显著差异(P=0.713)。对并发症的分析表明,COEC 组的肺实变发生率高于 SEC 组(P=0.007)。然而,当我们对 SEC 组和 COEC 组进行倾向评分匹配(PSM)时,Clavien-Dindo 分级的并发症仍无显著差异(P=0.346);此外,当对并发症进行详细分析时,两组之间也无显著差异。在亚组分析中,在对 ECL 患者和 SEC 患者进行 PSM 后,我们还发现 ECL 患者和 SEC 患者的术后并发症之间无显著差异。此外,我们发现,糖尿病史(OR=1.604,P=0.029,95%CI=1.049-2.454)、冠心病史(OR=1.592,P=0.046,95%CI=1.008-2.515)、一氧化碳弥散量(DLCO)(OR=0.916,P=0.024,95%CI=0.849-0.988)和 ALB 水平(OR=0.955,P=0.007,95%CI=0.924-0.987)是影响食管癌患者术后 III 级或以上并发症的独立因素。
食管癌联合手术并不增加术后并发症的发生率。此外,糖尿病或冠心病史、一氧化碳弥散量和术前 ALB 水平是食管癌术后 III 级或以上并发症的独立危险因素。